Research ArticleArticle
Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score–matched Cohort Study
Josefina Durán, Christine Peloquin, Yuqing Zhang and David T. Felson
The Journal of Rheumatology March 2017, jrheum.160930; DOI: https://doi.org/10.3899/jrheum.160930
Josefina Durán
From the Rheumatology Department, Pontificia Universidad Católica de Chile School of Medicine, Santiago, Chile; Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts, USA; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester UK National Institute for Health Research Biomedical Research Unit, Manchester, UK. Supported by P60 AR047785 US National Institute of Arthritis and Musculoskeletal and Skin Diseases Multidisciplinary Clinical Research Center grant. J. Durán, MD, MSc, Rheumatology Department, Pontificia Universidad Católica de Chile School of Medicine, and Clinical Epidemiology Unit, Boston University School of Medicine; C. Peloquin, MPH, Clinical Epidemiology Unit, Boston University School of Medicine; Y. Zhang, DSc, Clinical Epidemiology Unit, Boston University School of Medicine; D.T. Felson, MD, MPH, Clinical Epidemiology Unit, Boston University School of Medicine, and Arthritis Research UK Epidemiology Unit, University of Manchester, and Manchester UK National Institute for Health Research Biomedical Research Unit. Address correspondence to Dr. J. Durán, Marcoleta 350, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl. Accepted for publication January 4, 2017.
Christine Peloquin
From the Rheumatology Department, Pontificia Universidad Católica de Chile School of Medicine, Santiago, Chile; Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts, USA; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester UK National Institute for Health Research Biomedical Research Unit, Manchester, UK. Supported by P60 AR047785 US National Institute of Arthritis and Musculoskeletal and Skin Diseases Multidisciplinary Clinical Research Center grant. J. Durán, MD, MSc, Rheumatology Department, Pontificia Universidad Católica de Chile School of Medicine, and Clinical Epidemiology Unit, Boston University School of Medicine; C. Peloquin, MPH, Clinical Epidemiology Unit, Boston University School of Medicine; Y. Zhang, DSc, Clinical Epidemiology Unit, Boston University School of Medicine; D.T. Felson, MD, MPH, Clinical Epidemiology Unit, Boston University School of Medicine, and Arthritis Research UK Epidemiology Unit, University of Manchester, and Manchester UK National Institute for Health Research Biomedical Research Unit. Address correspondence to Dr. J. Durán, Marcoleta 350, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl. Accepted for publication January 4, 2017.
Yuqing Zhang
From the Rheumatology Department, Pontificia Universidad Católica de Chile School of Medicine, Santiago, Chile; Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts, USA; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester UK National Institute for Health Research Biomedical Research Unit, Manchester, UK. Supported by P60 AR047785 US National Institute of Arthritis and Musculoskeletal and Skin Diseases Multidisciplinary Clinical Research Center grant. J. Durán, MD, MSc, Rheumatology Department, Pontificia Universidad Católica de Chile School of Medicine, and Clinical Epidemiology Unit, Boston University School of Medicine; C. Peloquin, MPH, Clinical Epidemiology Unit, Boston University School of Medicine; Y. Zhang, DSc, Clinical Epidemiology Unit, Boston University School of Medicine; D.T. Felson, MD, MPH, Clinical Epidemiology Unit, Boston University School of Medicine, and Arthritis Research UK Epidemiology Unit, University of Manchester, and Manchester UK National Institute for Health Research Biomedical Research Unit. Address correspondence to Dr. J. Durán, Marcoleta 350, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl. Accepted for publication January 4, 2017.
David T. Felson
From the Rheumatology Department, Pontificia Universidad Católica de Chile School of Medicine, Santiago, Chile; Clinical Epidemiology Unit, Boston University School of Medicine, Boston, Massachusetts, USA; Arthritis Research UK Epidemiology Unit, University of Manchester; Manchester UK National Institute for Health Research Biomedical Research Unit, Manchester, UK. Supported by P60 AR047785 US National Institute of Arthritis and Musculoskeletal and Skin Diseases Multidisciplinary Clinical Research Center grant. J. Durán, MD, MSc, Rheumatology Department, Pontificia Universidad Católica de Chile School of Medicine, and Clinical Epidemiology Unit, Boston University School of Medicine; C. Peloquin, MPH, Clinical Epidemiology Unit, Boston University School of Medicine; Y. Zhang, DSc, Clinical Epidemiology Unit, Boston University School of Medicine; D.T. Felson, MD, MPH, Clinical Epidemiology Unit, Boston University School of Medicine, and Arthritis Research UK Epidemiology Unit, University of Manchester, and Manchester UK National Institute for Health Research Biomedical Research Unit. Address correspondence to Dr. J. Durán, Marcoleta 350, Santiago Centro, Santiago, Chile. E-mail: jgduran@uc.cl. Accepted for publication January 4, 2017.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score–matched Cohort Study
Josefina Durán, Christine Peloquin, Yuqing Zhang, David T. Felson
The Journal of Rheumatology Mar 2017, jrheum.160930; DOI: 10.3899/jrheum.160930